ArticleEULAR rheumatology open2026
From myositis to sarcoidosis: a rare autoimmune continuum.
Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcoidosis is a multisystem granulomatous disease that may rarely coexist with idiopathic inflammatory myopathies. The overlap of sarcoidosis and idiopathic inflammatory myopathy is exceptional and poses diagnostic difficulties due to overlapping clinical and laboratory findings. Case presentation: A 35-year-old woman presented with progressive proximal muscle weakness and dyspnoea. Electromyography revealed primary muscle fibre involvement, and serum creatine kinase levels were markedly elevated. Initial muscle biopsy was nondiagnostic. Two years later, mediastinal lymph node biopsy showed nonnecrotising granulomatous inflammation, consistent with sarcoidosis. Sarcoidosis was initially managed conservatively due to the absence of organ-threatening involvement. Over time, progressive muscle weakness and respiratory symptoms recurred. Magnetic resonance imaging of the lower extremities revealed diffuse muscle oedema and enhancement consistent with inflammatory myopathy. Repeat electromyography findings supported idiopathic inflammatory myopathy. Laboratory tests showed antinuclear antibody 1:320 cytoplasmic homogeneous positivity, whereas myositis-specific antibodies were negative. The patient was diagnosed with sarcoidosis-idiopathic inflammatory myopathy overlap syndrome. She achieved complete clinical and biochemical remission following treatment with oral corticosteroids and azathioprine. Conclusion: The coexistence of sarcoidosis and idiopathic inflammatory myopathy is rare but should be considered in patients with granulomatous disease and progressive myopathy. Recognition of this overlap is essential for timely diagnosis and immunosuppressive therapy, which may lead to full recovery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.